Clinical outcomes and the risk factors of coronary artery aneurysms that developed after drug-eluting stent implantation

Circulation Journal

Volumn 75, Issue 4, 2011, Pages 861-867

  Kim, Ung ^a   Seol, Sang Hoon ^a   Kim, Doo Il ^a   Kim, Dong Kie ^a   Jang, Jae Sik ^a   Yang, Tae Hyun ^a   Kim, Dae Kyeong ^a   Kim, Dong Soo ^a   Min, Ho Ki ^a   Choi, Kang Ju ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Aneurysm; Coronary artery; Drug eluting stent; Risk factors

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STENT THROMBOSIS;

AGED; CORONARY ANEURYSM; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79953666028     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0635     Document Type: Article

References (28)

1. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773-3780.
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
3. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008; 52: 1134-1140.
4. Windecker S, Meier B. Late coronary stent thrombosis. Circulation 2007; 116: 1952-1965.
5. Baumbach A, Bittl JA, Fleck E, Geschwind HJ, Sanborn TA, Tcheng JE, et al. Acute complications of excimer laser coronary angioplasty: A detailed analysis of multicenter results: Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries. J Am Coll Cardiol 1994; 23: 1305-1313.
6. Bell MR, Garratt KN, Bresnahan JF, Edwards WD, Holmes DR Jr. Relation of deep arterial resection and coronary artery aneurysms after directional coronary atherectomy. J Am Coll Cardiol 1992; 20: 1474-1481.
7. Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S. Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty: STRESS Trial Investigators. Am J Cardiol 1997; 79: 1104-1106.
8. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-732.
9. Abreu L, Meireles GC, Forte AA, Sumita M, Hayashi J, Solano J. Coronary artery aneurysm one year and five months after sirolimus-eluting stent placement. Arq Bras Cardiol 2005; 85: 340-342 (in Portuguese).
10. Levisay JP, Roth RM, Schatz RA. Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc Revasc Med 2008; 9: 284-287.
11. Anandaraja S, Naik N, Talwar K. Coronary artery aneurysm following drug-eluting stent implantation. J Invasive Cardiol 2006; 18: E66-E67.
12. Gupta RK, Sapra R, Kaul U. Early aneurysm formation after drugeluting stent implantation: An unusual life-threatening complication. J Invasive Cardiol 2006; 18: E140-E142.
13. Alfonso F, Perez-Vizcayno MJ, Ruiz M, Suarez A, Cazares M, Hernandez R, et al. Coronary aneurysms after drug-eluting stent implantation: Clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 2009; 53: 2053-2060.
14. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 2008; 1: 14-21.
15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
16. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005; 294: 1215-1223.
17. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
18. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002; 106: 2649-2651.
19. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705.
20. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058.
21. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175-181.
22. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation 2005; 111: 900-905.
23. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-419.
24. Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, et al. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke 2008; 39: 180-184.
25. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, Banuelos C, et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007; 50: 2095-2097.
26. Honda Y. Drug-eluting stents: Insights from invasive imaging technologies. Circ J 2009; 73: 1371-1380.
27. Hur SH, Ako J, Honda Y, Sudhir K, Fitzgerald PJ. Late-acquired incomplete stent apposition: Morphologic characterization. Cardiovasc Revasc Med 2009; 10: 234-246.
28. Shite J. Delayed neointimalization on drug-eluting stents: Speculation from optical coherence tomography. Circ J 2009; 73: 1033-1037.